# Hatteras Venture Partners' Biotech Investments: 31 Startups in Its Portfolio (2026) > The 31 Biotech startups Hatteras Venture Partners has backed, by stage: $2.4B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/hatteras-venture-partners-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series A 10 - [Axonis Therapeutics](https://millionrounds.com/company/axonis-therapeutics) - [Code Biotherapeutics](https://millionrounds.com/company/code-biotherapeutics) - [Ribometrix](https://millionrounds.com/company/ribometrix) - [Specific Biologics](https://millionrounds.com/company/specific-biologics) - [*Q* Qpex](https://millionrounds.com/company/qpex) - [*TT* Trefoil Therapueitcs](https://millionrounds.com/company/trefoil-therapueitcs) - [Qvella Corporation](https://millionrounds.com/company/qvella-corporation) - [Spyryx Biosciences](https://millionrounds.com/company/spyryx-biosciences) - [*B* Boragen](https://millionrounds.com/company/boragen) - [Pathfinder Therapeutics](https://millionrounds.com/company/pathfinder-therapeutics) ## Series C and later 7 - [Kymera Therapeutics](https://millionrounds.com/company/kymera-therapeutics) - [Elligo Health Research](https://millionrounds.com/company/elligo-health-research) - [Atsena Therapeutics](https://millionrounds.com/company/atsena-therapeutics) - [Clearside Biomedical](https://millionrounds.com/company/clearside-biomedical) - [*P* PhaseBio](https://millionrounds.com/company/phasebio) - [Rodin Therapeutics](https://millionrounds.com/company/rodin-therapeutics) - [*EH* Elligo Health](https://millionrounds.com/company/elligo-health) ## Stage not reported 7 - [Veralox Therapeutics](https://millionrounds.com/company/veralox-therapeutics) - [Trefoil Therapeutics](https://millionrounds.com/company/trefoil-therapeutics) - [Artizan Biosciences](https://millionrounds.com/company/artizan-biosciences) - [BEKHealth](https://millionrounds.com/company/bekhealth) - [Boston Immune Technologies & Therapeutics](https://millionrounds.com/company/boston-immune-technologies-and-therapeutics) - [ORIG3N](https://millionrounds.com/company/orig3n) - [Altis Biosystems](https://millionrounds.com/company/altis-biosystems) ## Series B 7 - [CREATE Medicines](https://millionrounds.com/company/create-medicines) - [Tune Therapeutics](https://millionrounds.com/company/tune-therapeutics) - [Vigil Neuroscience](https://millionrounds.com/company/vigil-neuroscience) - [*N* NeuroTronik](https://millionrounds.com/company/neurotronik) - [Coferon](https://millionrounds.com/company/coferon) - [*Q* Qvella](https://millionrounds.com/company/qvella) - [Incyclix Bio](https://millionrounds.com/company/incyclix-bio) ## Segment by segment ### Series A 10 startups · $386M raised - [**Axonis Therapeutics**](https://millionrounds.com/company/axonis-therapeutics) Axonis Therapeutics is a Boston-based biotechnology company founded in 2019, focused on developing innovative oral therapies for n United States $115M - [**Code Biotherapeutics**](https://millionrounds.com/company/code-biotherapeutics) Code Biotherapeutics (Code Bio) is a biotechnology company founded in 2020, based in Hatfield, Pennsylvania. United States $75M - [**Ribometrix**](https://millionrounds.com/company/ribometrix) Ribometrix is a platform therapeutics company that discovers small molecule drugs to treat human diseases. United States $45M - [**Specific Biologics**](https://millionrounds.com/company/specific-biologics) Specific Biologics develops novel gene editing technologies to treat diseases at the genetic level in cells inside the body. Canada $36M - [*Q* **Qpex**](https://millionrounds.com/company/qpex) United States $33M - [*TT* **Trefoil Therapueitcs**](https://millionrounds.com/company/trefoil-therapueitcs) United States $28M - [**Qvella Corporation**](https://millionrounds.com/company/qvella-corporation) Qvella Corporation is a leader in molecular diagnostics focused on improving the speed and efficiency of diagnosing sepsis and blo Canada $20M - [**Spyryx Biosciences**](https://millionrounds.com/company/spyryx-biosciences) Spyryx Biosciences develops a next-generation therapeutics for obstructive lung diseases. United States $18M ### Series C and later 7 startups · $1.3B raised - [**Kymera Therapeutics**](https://millionrounds.com/company/kymera-therapeutics) Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation. United States $799M - [**Elligo Health Research**](https://millionrounds.com/company/elligo-health-research) Elligo Health Research brings clinical research to physician practices and accelerate the development of medical device and therapies. United States $160M - [**Atsena Therapeutics**](https://millionrounds.com/company/atsena-therapeutics) Atsena Therapeutics is a clinical-stage gene therapy company based in Durham, North Carolina, focused on developing treatments for United States $150M - [**Clearside Biomedical**](https://millionrounds.com/company/clearside-biomedical) Clearside BioMedical is an ophthalmic company that specializes in the research, development, and commercialization of therapeutic products. United States $72M - [*P* **PhaseBio**](https://millionrounds.com/company/phasebio) United States $50M - [**Rodin Therapeutics**](https://millionrounds.com/company/rodin-therapeutics) Rodin Therapeutics develops novel therapeutics for neurological disorders by applying insights of epigenetics. United States $40M - [*EH* **Elligo Health**](https://millionrounds.com/company/elligo-health) United States $36M ### Stage not reported 7 startups · $105M raised - [**Veralox Therapeutics**](https://millionrounds.com/company/veralox-therapeutics) VERALOX Therapeutics is a clinical-stage biotechnology company based in Frederick, Maryland. United States $41M - [**Trefoil Therapeutics**](https://millionrounds.com/company/trefoil-therapeutics) Trefoil is a biotechnology company that brings forward novel engineered FGF-1 compounds to treat endothelial cell mediated diseases. United States $33M - [**Artizan Biosciences**](https://millionrounds.com/company/artizan-biosciences) Artizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal microbiota. United States $14M - [**BEKHealth**](https://millionrounds.com/company/bekhealth) BEKhealth is an AI-powered clinical intelligence company that enhances electronic health record (EHR) data for clinical research. United States $9.0M - [**Boston Immune Technologies & Therapeutics**](https://millionrounds.com/company/boston-immune-technologies-and-therapeutics) This company is a Boston-based biopharmaceutical company developing immune-based approaches. United States $4.0M - [**ORIG3N**](https://millionrounds.com/company/orig3n) ORIG3N is a biotechnology company based in Boston, founded in 2014. United States $3.1M - [**Altis Biosystems**](https://millionrounds.com/company/altis-biosystems) Altis Biosystems is a scientific innovation company based in Durham, NC, focused on advancing pre-clinical drug discovery. United States $2.1M ### Series B 7 startups · $601M raised - [**CREATE Medicines**](https://millionrounds.com/company/create-medicines) CREATE Medicines is a clinical-stage biotechnology company based in Cambridge, Massachusetts. United States $195M - [**Tune Therapeutics**](https://millionrounds.com/company/tune-therapeutics) Tune Therapeutics is a biotechnology company based in Durham, North Carolina, founded in 2020. United States $175M - [**Vigil Neuroscience**](https://millionrounds.com/company/vigil-neuroscience) Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases. United States $130M - [*N* **NeuroTronik**](https://millionrounds.com/company/neurotronik) Neuro Tronik develops a medical device as an alternative for the drugs used currently to treat heart failures. United States $36M - [**Coferon**](https://millionrounds.com/company/coferon) Coferon employs bioorthogonal linker chemistry to deliver therapeutic molecules in component parts that self assembles inside target cells. United States $28M - [*Q* **Qvella**](https://millionrounds.com/company/qvella) Canada $20M - [**Incyclix Bio**](https://millionrounds.com/company/incyclix-bio) Incyclix Bio, LLC is a biotechnology company based in Research Triangle Park, North Carolina, founded in 2020 by experts in cyclin United States $16M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Hatteras Venture Partners as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Co-investors **Who invests with Hatteras Venture Partners** 36 co-investors](https://millionrounds.com/portfolio-maps/hatteras-venture-partners-co-investors)[Sector portfolio **Techstars' AI portfolio** 336 startups · $4.9B](https://millionrounds.com/portfolio-maps/techstars-ai-portfolio)[Sector portfolio **Alumni Ventures' AI portfolio** 302 startups · $36B](https://millionrounds.com/portfolio-maps/us-strategic-tech-fund-an-alumni-ventures-fund-ai-portfolio)[Sector portfolio **Andreessen Horowitz's AI portfolio** 259 startups · $426B](https://millionrounds.com/portfolio-maps/andreessen-horowitz-ai-portfolio)[Sector portfolio **General Catalyst's AI portfolio** 226 startups · $179B](https://millionrounds.com/portfolio-maps/general-catalyst-ai-portfolio)[Sector portfolio **Sequoia Capital's AI portfolio** 209 startups · $543B](https://millionrounds.com/portfolio-maps/sequoia-capital-ai-portfolio) ## Raising from investors like Hatteras Venture Partners? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)